MyHeart Counts Cardiovascular Health Study (MHC)

May 22, 2025 updated by: Euan Ashley, Stanford University

The MyHeart Counts Cardiovascular Health Study will utilize mobile health capabilities of smartphones and wearables to assess daily activity measures of the general population and compare these to measures of cardiovascular health risk factors and fitness. How people divide their time among exercise, sedentary behavior, and sleep all affect cardiovascular health, yet to date these have largely gone unmeasured. With the advancement of phone sensors and wearable fitness tracking devices these factors are now more straightforward to gather and measure. The use of smartphones by a large segment of the population allows for data collection on an unprecedented scale. The investigators aim to amass activity and cardiovascular health data on thousands of participants as well as provide significantly more quantitative data on type,duration, and intensity of daily activities.

In the second phase of the MyHeart Counts Cardiovascular Health Study (Randomized Assessment of Physical Activity Prompts In A Large Ambulatory Population) the researchers will conduct a randomized controlled clinical trial of four different physical activity prompts (intervention) and their effect on the level of physical activity in the study population as measured by change in step count.

Study Overview

Detailed Description

MyHeart Counts Cardiovascular Health Study is a smartphone-based mobile cardiovascular health research study. The study will utilize the mobile health capabilities of smartphones and wearables to assess daily activity measures of the general public and compare these to measures of cardiovascular health - risk factors and fitness. How people divide their time among exercise, sedentary behavior, and sleep all affect cardiovascular health, yet these largely go unmeasured. With the advancement in phone sensors and wearables these factors are now more straightforward to gather and measure. The use of smartphones by a large segment of the population allows for data collection on an unprecedented scale. The investigators aim to amass activity and cardiovascular health data on thousands of participants as well as provide much more quantitative data on type,duration, and intensity of daily activities. The MyHeart Counts Cardiovascular Health mobile application provides a platform for the investigation of methods aimed to aid participants in increasing heart healthy activities. The overall goal of the study is to develop an extensive source of data which will inform future cardiovascular health guidelines.

In the second phase of the MyHeart Counts Cardiovascular Health Study (Randomized Assessment of Physical Activity Prompts In A Large Ambulatory Population) the investigators will conduct a randomized controlled clinical trial of four different physical activity prompts (intervention) and their effect on increasing physical activity in the study population as measured by change in step count.

Of note to supplement the activity data the investigators will ask participants who have completed a genetic analysis to share their that data with the MyHeart Counts Cardiovascular Health Study research team. The investigators believe the opportunity to overlay activity, heart risk and genetic data for participants is a great tool for discovery.

Study Type

Interventional

Enrollment (Estimated)

2000000

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Stanford, California, United States, 94305
        • Stanford University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • All adults over the age of 18

Exclusion Criteria:

  • Children under the age of 18

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Stand Prompt
Behavioral Intervention Prompt- Participant will receive a notification asking them to stand and walk if they have been sitting for longer than 60 minutes.
The participant will receive a notification asking them to stand or walk if they have been sitting for longer than 60 minutes
Other Names:
  • Behavior Change and Motivational Coaching-Stand Prompt
Active Comparator: Step Prompt
The participant will receive a notification if they are below 5000 steps by 3pm each day asking them to get to 10000 steps.
The participant will receive a notification if they are below 5000 steps by 3pm each day asking them to get to 10000 steps.
Other Names:
  • Behavior Change and Motivational Coaching- Step Prompt
Active Comparator: Cluster Prompt
The participant will receive daily information notifications specific to the activity cluster they fall into based on the activity data collected in phase 1 of the study.
The participant will receive daily information notifications specific to the activity cluster they fall into based on the activity data collected in phase 1 of the study
Other Names:
  • Behavior Change and Motivational Coaching- Cluster Prompt
Placebo Comparator: Read AHA website
Daily reminder to read the American Heart Association (AHA) website.
Daily reminder to read the newsfeed from the American Heart Association (AHA) website, this is a control arm
Other Names:
  • Behaviour Change and Motivational Coaching- Reminder to read the American Heart Association (AHA) website
No Intervention: Baseline monitoring
No feedback is provided to the users. This is the control arm.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Activity frequency and duration as Measured By Smartphone Core Motion Chip Sensor (Step count as seen in Apple's Healthkit)
Time Frame: 5 weeks
The researchers will compare step count data collected during baseline (or phase 1) week with step count data at the end of each of the 4 intervention weeks.
5 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in self reported levels of happiness as indicated on a numerical gradient scale and self reported by participant using the OECD Guidelines on Measuring Subjective Well Being survey
Time Frame: 5 weeks
5 weeks
Change in responses ( to survey questions on self perceived risk of cardiovascular disease and well being (survey adopted from reference in description)
Time Frame: 5 weeks
Each answer prompt on the survey is given a unique numerical value which is then added and averaged. The researchers will investigate for changes in this score at baseline and during interventions.
5 weeks
Change in sleep duration as measured by Apples core motion chip.
Time Frame: 5 weeks
The iphone is able to track sleep by sensing lack of motion between self reported sleeping and wake times. The investigators will compare the average sleep time detected by phone at baseline and at the end of each intervention week.
5 weeks
Change in self reported sleep duration obtained from a daily user survey.
Time Frame: 5 weeks
The researchers will compare self reported sleep time at baseline vs end of each intervention week.
5 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Euan Ashley, MD, Stanford University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2015

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

December 1, 2029

Study Registration Dates

First Submitted

December 14, 2016

First Submitted That Met QC Criteria

March 18, 2017

First Posted (Actual)

March 24, 2017

Study Record Updates

Last Update Posted (Actual)

May 29, 2025

Last Update Submitted That Met QC Criteria

May 22, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 31409 (Other Identifier: Temple University)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Individual user data will not be shared, deidentified user data will be shared if the user has indicated that this is ok with them.

Drug and device information, study documents

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe